Exagen Inc.
XGN
$3.02
-$0.15-4.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.55% | 0.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.55% | 0.24% | |||
| Cost of Revenue | 3.57% | 5.32% | |||
| Gross Profit | -8.63% | -3.08% | |||
| SG&A Expenses | 8.55% | -0.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.20% | 2.58% | |||
| Operating Income | -60.48% | -17.87% | |||
| Income Before Tax | 34.24% | -60.97% | |||
| Income Tax Expenses | 1,200.00% | -97.30% | |||
| Earnings from Continuing Operations | 34.06% | -59.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 34.06% | -59.65% | |||
| EBIT | -60.48% | -17.87% | |||
| EBITDA | -75.84% | -14.97% | |||
| EPS Basic | 35.84% | -46.75% | |||
| Normalized Basic EPS | -37.99% | -10.57% | |||
| EPS Diluted | 35.84% | -46.75% | |||
| Normalized Diluted EPS | -37.99% | -10.57% | |||
| Average Basic Shares Outstanding | 2.77% | 8.80% | |||
| Average Diluted Shares Outstanding | 2.77% | 8.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||